{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"4","upperLimit":"8","value":"5.1"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"14"}],"units":"Participants"}],"description":"Whether treatment was administered in the time frame based on the high throughput drug screen. Time from sample procurement to assay results.","dispersionType":"Full Range","groups":[{"description":"14 patients were treated.","id":"OG000","title":"Treated Patients"}],"paramType":"MEDIAN","populationDescription":"14 patients were treated.","reportingStatus":"POSTED","timeFrame":"Up to 21 days","title":"Achievability of Performing Individualized Drug Screening and Initiating Therapy Based on the Results of the Drug Screen for Poor Risk Patients With Relapsed or Refractory AML","type":"PRIMARY","unitOfMeasure":"days"}